8-K
Current Report
Boundless Bio, Inc. Filed Acc 0000950170-25-076911
Exit or restructuring costs · Other events
- Item 2.05 Costs associated with exit or disposal activities
- Item 8.01 Other events
From the SEC's structured data for this filing
Loading bold-20250523.htm…